Victoria Song is a senior reviewer for The Verge and author of Optimizer, a weekly newsletter that cuts through the hype to uncover what tech actually makes your life better. She specializes in emerging technologies in wearables, health and fitness, and XR. Before coming to The Verge, she’s been reporting on consumer tech for Gizmodo and PC Magazine. In another life, she worked on the business and breaking news desk for The Yomiuri Shimbun. When not nerding out, she can be found swearing while running or on the couch binging the latest K-dramas. You can reach her on Signal: @vicmsong.14
The GLP-1 tech boom is coming.
So says Meta spokesperson Che’von Lewis. Senior was previously Meta’s Product Lead for its Studio and New Vertical portfolios. You can read more about Supernatural’s forthcoming era here, and catch up on the buff ladies who worked so hard to save it here.
First off, it announced today that it plans to acquire Nutrisense — a CGM startup that targets nondiabetics. Stelo, its over-the-counter CGM, is also getting an FDA-cleared redesign that includes “pattern recognition, proactive AI coaching, and personalized weekly and daily summaries.” Hopefully, these moves help ease the data fatigue I experienced in my yearlong experiment with CGMs as a nondiabetic.
Biohackers say drugs can help you be your best self. It’s hard to spot when they’re not telling the whole truth.
There’s also a ton of new software updates coming, including GLP-1 insights.
Well, I was too busy putting the finishing touches on my feature about the Enhanced Games to notice that the company is now offering a $10 million prize for sprinters who can break Usain Bolt’s 100m record of 9.58 seconds at the Enhanced Games 2027. Oh boy. Here we go.
On the ground at the invite-only ‘Steroid Olympics’ in Vegas, where the athletes are the experiment.
